Neural networks that regulate an organism's internal environment must sense perturbations, respond appropriately, and then reset. These adaptations should be reflected as changes in the efficacy of the synapses that drive the final output of these homeostatic networks. Here we show that hemorrhage, an in vivo challenge to fluid homeostasis, induces LTD at glutamate synapses onto hypothalamic magnocellular neurosecretory cells (MNCs). LTD requires the activation of postsynaptic a2-adrenoceptors and the production of endocannabinoids that act in a retrograde fashion to inhibit glutamate release. In addition, both hemorrhage and noradrenaline downregulate presynaptic group III mGluRs. This loss of mGluR function allows high-frequency activity to potentiate these synapses from their depressed state. These findings demonstrate that noradrenaline controls a form of metaplasticity that may underlie the resetting of homeostatic networks following a successful response to an acute physiological challenge.
INTRODUCTION
The survival of an organism depends upon its ability to quickly, effectively, and repeatedly defend homeostatic setpoints. This requires neural networks that regulate autonomic and neuroendocrine outputs to possess intrinsic mechanisms that allow them to respond to a challenge, adapt, and then reset. The precise nature of these mechanisms remains unresolved. Here we hypothesized that bidirectional changes in synaptic strength may be particularly useful in regulating the output of networks that must make continual adjustments in response to momentto-moment changes in physiological input.
While persistent changes in synaptic efficacy, such as longterm potentiation (LTP) and long-term depression (LTD), are essential for information storage in neural networks (Malenka and Bear, 2004) , a complementary mechanism, metaplasticity, maintains network stability and ensures that synapses operate within a functional dynamic range by modifying the expression of synaptic plasticity as a function of prior activity (Abraham, 2008) . Presynaptic metabotropic glutamate receptors (mGluRs), which regulate the release of neurotransmitter at nerve terminals, have recently been implicated in a novel form of metaplasticity in the hippocampus (Pelkey et al., 2005) . In this scenario, group III mGluRs undergo agonist-induced internalization, unmasking a state permissive for subsequent activity-dependent LTP of glutamate synapses. Loss of mGluR function has also been reported at glutamatergic synapses onto hypothalamic magnocellular neurosecretory cells (MNCs) in the paraventricular nucleus of the hypothalamus (PVN) (Gordon and Bains, 2003) . These neurons integrate local and synaptic information regarding blood volume and make neuroendocrine adjustments to maintain body fluid homeostasis (Bourque, 2008; Poulain and Wakerley, 1982) . A precipitous drop in blood volume triggers an immediate increase in the activity of these cells (Poulain et al., 1977; Wakerly et al., 1975) that is driven by the release of noradrenaline (NA) from ascending fibers (Buller et al., 1999) . While this causes an immediate increase in neuronal activity through synaptic actions that increase quantal glutamate release (Boudaba et al., 2003; Gordon and Bains, 2003) and promote the postsynaptic insertion of AMPA receptors , NA is also the substrate necessary for the functional inactivation of presynaptic highaffinity, group III mGluRs (Gordon and Bains, 2003) .
Here we asked whether glutamate synapses onto MNCs adapt following in vivo hemorrhage and then whether these adaptations would favor an activity-dependent resetting of these synapses. Using whole-cell patch-clamp recordings from MNCs in hypothalamic brain slices, we demonstrate that in vivo hemorrhage-induced release of NA in the PVN decreases the probability of evoked glutamate release onto MNCs. This LTD is mimicked by bath application of NA to naive slices and is accompanied by a complete loss of function of group III mGluRs. Subsequent high-frequency stimulation (HFS) can cause both restoration of synaptic strength and a gain of mGluR function. These observations demonstrate that mGluRs are essential for metaplastic synaptic changes that may allow networks regulating fluid homeostasis to adapt and reset.
RESULTS

Presynaptic LTD following In Vivo Hemorrhage
To examine synaptic changes responsible for restoring body fluid volume homeostasis, we assessed synaptic efficacy in hypothalamic slices obtained from rats that had been subjected to a hypovolemic hemorrhage (removal of 25% blood volume), a stimulus that strongly activates MNCs in the PVN of the hypothalamus (Buller et al., 1999; Poulain et al., 1977; Wakerly et al., 1975) . Brain slices containing the PVN were prepared 30 min after the hemorrhage to allow a sustained period of noradrenergic drive and increased neuronal activity. Glutamatergic synaptic transmission was examined in acute rat hypothalamic slices by recording from visually and electrophysiologically identified (Luther and Tasker, 2000) MNCs in the PVN. In comparison to control slices, evoked excitatory postsynaptic currents (eEPSCs) recorded from hemorrhaged rats displayed a lower probability of glutamate release (Pr) as indicated by a significantly enhanced paired-pulse ratio (PPR; EPSC2/EPSC1: control 1.51 ± 0.07; n = 57; hemorrhage 1.95 ± 0.19; n = 15; p = 0.009), more synaptic failures (failure rate, failures/30 events: control 0.04 ± 0.01; hemorrhage 0.15 ± 0.04; p = 0.0004), and an increase in the coefficient of variation (CV; standard deviation/ mean; control 0.39 ± 0.02; hemorrhage 0.50 ± 0.04; p = 0.02; Figures 1A and 1B) . These measures of reduced synaptic release efficacy persisted for at least 4.5 hr after slicing. No significant changes in PPR were noted if brain slices were prepared immediately (2 min) following the hemorrhage (control 1.51 ± 0.07; n = 57; 2 min hemorrhage 1.35 ± 0.13; n = 18; p = 0.28). These observations indicate that glutamate synapses onto MNCs exhibit a presynaptic LTD following hemorrhage. 
. Hemorrhage Lowers Pr at Glutamate Synapses
(A) eEPSCs in slices obtained from hemorrhaged rats (blue) displayed an increased PPR when compared with controls (black). Current traces are averages of 30 consecutive responses from each condition. For paired-pulse recordings, synaptic stimuli were delivered 50 ms apart. Scale bars: 10 ms, 20 pA. (B) Summary graph illustrating that hemorrhaged rats (blue; n = 15) had a reduced Pr compared to nonhemorrhaged naive rats (black; n = 57), indicated by significant increases in PPR, failure rate, and CV. *p < 0.05, **p < 0.01. (C-E) Example of an injection site from animals microinjected with prazosin, yohimbine, or vehicle into the PVN prior to hemorrhage. The image shown is from case 5 of the yohimbine-injected group (see Figure S1 ). (F-H) Bar chart summaries of PPR, failure rate, and CV of eEPSCs obtained from control naive slices (control; n = 57) and slices from animals with yohimbine (10 nmol; n = 6), prazosin (10 nmol; n = 8), or vehicle (n = 4) microinjected into the PVN prior to hemorrhage.
Since perturbations to body fluid homeostasis sensed by peripheral receptors are relayed by noradrenergic fibers to neurons in the hypothalamus (Buller et al., 1999; Sawchenko and Swanson, 1981) , we hypothesized that LTD following hemorrhage was mediated via activation of noradrenergic receptors. To test this directly we microinjected subtype selective adrenoceptor antagonists directly into the PVN prior to hemorrhaging the rat ( Figures 1C-1E ). Figure S1 (available online) shows the distribution of the localized injection sites for all subjects. Microinjection of the a2-adrenoceptor antagonist yohimbine (10 nmol) blocked the hemorrhage-mediated LTD (PPR 1.37 ± 0.14; n = 6; p = 0.53; failure rate 0.04 ± 0.019; p = 0.92; CV 0.38 ± 0.049; p = 0.8; Figures 1F-1H ). In contrast, microinjection of the a1-adrenoceptor antagonist prazosin (10 nmol) into the PVN failed to prevent LTD following hemorrhage (PPR 2.06 ± 0.43; n = 8; p = 0.02; failure rate 0.18 ± 0.08; p = 0.0009; CV 0.58 ± 0.12; p = 0.009). Vehicle injection had no effect on hemorrhage-induced LTD (PPR 1.95 ± 0.53; n = 4; p = 0.06; failure rate 0.12 ± 0.029; p = 0.04; CV 0.58 ± 0.027; p = 0.01). These results demonstrate that hemorrhage results in LTD of glutamate synapses that requires the activation of a2, but not a1, -adrenoceptors.
a2-Adrenoceptors and Endocannabinoids
Are Required for NA-Induced LTD We next determined the mechanism through which a2-adrenoceptor activation induces LTD. In slices from naive, nonhemorrhaged rats bath application of NA (100 mM; 5 min) produced a rapid depression of eEPSCs that relaxed to a less robust, but LTD (LTD NA ; eEPSC amplitude = 56.28% ± 6.67% of control; n = 17; p < 0.0001; Figures 2A and 2B ). Similar to LTD observed following hemorrhage, LTD NA was also associated with an increase in PPR (control 1.32 ± 0.10; post-NA 1.69 ± 0.17; n = 7; p = 0.02; Figure 2C ), an increase in the failure rate (control 0.08 ± 0.05; post-NA 0.47 ± 0.14; p = 0.02), and an increase in CV (control 0.49 ± 0.09; post-NA 0.76 ± 0.14; p = 0.01).
To more carefully determine the adrenoceptor subtypes necessary for LTD NA , we conducted a number of pharmacological experiments. To test whether a1-adrenoceptors were necessary for LTD NA , we bath-applied the selective a1-adrenoceptor agonist phenylephrine (PE; 50 mM). This failed to elicit LTD NA (eEPSC amplitude = 122.78% ± 23.55% of control; n = 5; p = 0.39; Figure 3F ). In addition, the specific a1-adrenoceptor antagonist prazosin (10 mM) failed to block induction of LTD NA in response to bath application of NA (eEPSC amplitude = 68.76% ± 6.27% of control; n = 5; p = 0.04; Figure 3F ), a result consistent with the observed synaptic efficacy after in vivo hemorrhage. Conversely, application of the a2-adrenoceptorsubtype-selective antagonist yohimbine (20 mM) prior to and during NA application prevented induction of LTD NA (eEPSC amplitude = 93.20% ± 5.36% of control; n = 7; p = 0.22; Figures  3A and 3F) . If, however, yohimbine was applied after the induction of LTD NA , synapses remained depressed (eEPSC amplitude = 59.23% ± 12.85%; n = 5; p = 0.04; Figure 3F ). Application of the a2-adrenoceptor agonist clonidine (50 mM) also caused a long-lasting presynaptically expressed depression of evoked glutamate release (eEPSC amplitude = 57.07% ± 7.65% of control; n = 6; p = 0.009; PPR control 1.25 ± 0.23; PPR clonidine 2.70 ± 0.68; Figures 3B and 3F ). This depression was not due to slow unbinding of clonidine from the a2-adrenoceptor because application of a yohimbine chaser after induction of LTD NA had no effect ( Figure 3B ).
While the above observations strongly suggest that LTD NA requires a2-adrenoceptors and is expressed presynaptically as a reduction in glutamate Pr, they do not rule out the possibility that a2-adrenoceptors are located on the postsynaptic cell and when activated, produce a retrograde signal that depresses glutamate release. Indeed, there is compelling evidence for postsynaptic a2-adrenoceptors on MNCs in the PVN (Shirasaka et al., 2007) as well as in other brain structures (Carr et al., 2007; Cathala et al., 2002; Li and van den Pol, 2005; Liu and Alreja, 1998; Yamanaka et al., 2006) , strengthening evidence that activation of postsynaptic G i/o -coupled receptors can promote endocannabinoid (eCB) production through activation of phospholipase D (PLD) (Basavarajappa, 2007; Di Marzo et al., 1994; Jinsi-Parimoo and Deth, 1997; Senogles, 2000) , and that CB1 receptors are located on nerve terminals in the hypothalamic magnocellular neurosecretory system (Di et al., 2005a; Hirasawa et al., 2004; Oliet et al., 2007) . We directly tested for the involvement of postsynaptic a2-adrenoceptors by conducting experiments in which we included GDP-bs (1 mM) in our patch pipette to block postsynaptic G protein signaling. Following perfusion of the postsynaptic cell with GDP-bs for at least 10 min, application of clonidine had no effect on eEPSCs amplitude (eEPSC amplitude = 104.56% ± 8.94%; n = 8, p = 0.87; Figure 3C ). This indicates that a2-adrenoceptors are located on the postsynaptic membrane. Since other G i/o -coupled receptors act to depress transmitter release through the recruitment of eCBs (Giuffrida et al., 1999; Kreitzer and Malenka, 2007; Melis et al., 2004; Yin and Lovinger, 2006) , we conducted additional experiments in which NA was bath applied in the presence of a CB1 receptor
The induction of LTD NA was prevented under these experimental conditions (eEPSC amplitude = 116.34% ± 12.07% of control; n = 8; p = 0.30; Figure 3D ).
It is not clear whether eCB production following activation of G i/o -coupled receptors is Ca 2+ dependent. There is evidence to support a direct, Ca
2+
-independent action of PLD (Jin et al., 2007) , but PLD also exhibits, if not a requirement for Ca 2+ , then at least a reliance on Ca 2+ (Kano et al., 2009; Ueda et al., 2001 ). To determine whether a2-induced eCB production relies on postsynaptic Ca
, we loaded the postsynaptic cell with the Ca 2+ chelator BAPTA (10 mM) (Gerdeman et al., 2002; Robbe et al., 2002) . Under these conditions, NA failed to induce LTD NA (eEPSC amplitude = 95.64% ± 14.88% of control; n = 12; p = 0.22; Figure 3E ). These observations show that LTD NA requires the activation of postsynaptic a2-adrenoceptors, which recruits, in a Ca 2+ -dependent fashion, the production of eCBs that act on the presynaptic nerve terminal to decrease glutamate release.
LTD Is Accompanied by an a1-Mediated Functional Downregulation of Group III mGluRs
In addition to activating a2-adrenoceptors, the release of NA during hemorrhage will also stimulate a1-adrenoceptors. These receptors are located on both the presynaptic nerve terminal and neighboring astrocytes . The activation of presynaptic a1-adrenoceptors functionally inactivates highaffinity group III mGluRs at synapses onto MNCs in the PVN (Gordon and Bains, 2003) . Since group III mGluRs gate metaplasticity in the hippocampus (Pelkey et al., 2005 , we hypothesized that NA released during hemorrhage or bath applied in vitro to induce LTD NA may inactivate group III mGluRs in the PVN, which would serve as a molecular switch for the induction of activity-dependent synaptic potentiation.
To investigate the role of mGluRs at glutamatergic synapses onto MNCs under basal conditions, we bath applied the group III selective agonist L-2-amino-4-phosphonobutyric acid (L-AP4; 25 mM), which at this dose activates the high-affinity mGluR4 and (E) Summary of NA experiments where 10 mM BAPTA was included in the patch pipette. BAPTA was allowed to perfuse into the neuron for at least 15 min before NA was applied (n = 12). Inset scale bars: 10 ms, 100 pA. (F) Summary data showing the percent change in eEPSC amplitude after 20 min wash of NA (100 mM; n = 17), phenylephrine (PE; 50 mM; n = 5), NA in prazosin (praz + NA; 10 mM; n = 5), NA in yohimbine (yoh + NA; 20 mM; n = 7), NA chased with yohimbine (NA + yoh chaser; n = 5), clonidine (clon; 50 mM; n = 6), clonidine followed by a yohimbine chaser (clon + yoh chaser; n = 7), clonidine in cells patched with GDP-bs included in the intracellular solution (GDP-bs + clon; n = 8), NA in the presence of AM251 (AM251 + NA), and NA in cells patched with an intracellular solution containing BAPTA (BAPTA + NA). *p < 0.05; **p < 0.01. 8 subtypes. Following a stable baseline period of recording (5-10 min), L-AP4 elicited a reversible decrease in the amplitude of eEPSCs (73.26% ± 7.48% of control; n = 9; p = 0.03; Figure 4A ). This was accompanied by increases in PPR (control 1.60 ± 0.14; L-AP4 2.04 ± 0.30; p = 0.04; Figure 4B ), failure rate (control 0.07 ± 0.04; L-AP4 0.13 ± 0.05; p = 0.11), and CV (control 0.34 ± 0.03; L-AP4 0.44 ± 0.05; p = 0.04), indicating a reduction in the Pr of glutamate, consistent with group III mGluR inhibition of quantal (action-potential-independent) glutamate release (Oliet et al., 2001; Panatier et al., 2004; Schrader and Tasker, 1997) . In addition, application of the selective group III mGluR antagonist (RS)-a-methylserine-O-phosphate (MSOP; 100 mM) resulted in an increase in the amplitude of eEPSCs (119.28% ± 10.95% of control; n = 7; p = 0.04; Figure S4 ) and a decrease in the PPR (83.70% ± 5.77% of control, p = 0.03), suggesting that mGluRs are tonically active at glutamate synapses onto MNCs (Schrader and Tasker, 1997) .
Since a1-adrenoceptor activation is coupled to a downregulation of presynaptic group III mGluRs (Gordon and Bains, 2003) , we hypothesized that the effects of L-AP4 would be mitigated following either hemorrhage or NA application. Consistent with this idea, L-AP4 perfusion had no effect on eEPSCs in slices from hemorrhaged rats (98.73% ± 4.68% of control amplitude; n = 5; p = 0.95; PPR 102.48% ± 8.37%; p = 0.96; Figures 4C, 4G , and 4H). Moreover, L-AP4 failed to depress synapses from animals that were microinjected with the a2-adrenoceptor antagonist yohimbine into the PVN prior to hemorrhaging and slicing (105.76% ± 4.66% control; n = 5; Figure 4D ). Thus, the in vivo yohimbine microinjection prevented induction of a2-adrenoceptor-mediated LTD ( Figures 1F-1H ), but did not prevent the concomitant a1-adrenoceptor-mediated inactivation of group III mGluRs ( Figures 4D, 4G , and 4H).
To confirm the role of NA in the inactivation of mGluRs, we tested the effects of L-AP4 on evoked transmission at synapses that had (G and H) Summary bar graphs illustrating the effect of L-AP4 on the amplitude of evoked glutamate release (G) and PPR (H) in slices obtained from control naive rats (con; black), after induction of LTD NA (NA; red; n = 5), after clonidine LTD (clon; orange; n = 8), after in vivo hemorrhage (hem; blue; n = 5), and after microinjection of yohimbine into the PVN followed by hemorrhage (hem + yoh; n = 5). *p < 0.05. undergone LTD NA . Under these conditions, L-AP4 had no further effect on eEPSCs (105.21% ± 7.88% of LTD NA values; n = 5; p = 0.43; Figures 4E, 4G , and 4H), indicating that after induction of LTD NA , high-affinity group III mGluRs are inactivated/internalized. To be certain that the lack of effect of L-AP4 on synaptic transmission is due to inactivation of mGluRs and not a floor effect, we applied L-AP4 to slices that had undergone clonidine-mediated LTD. Here, mGluRs should still be active and in these experiments, L-AP4 caused a depression of eEPSC amplitude (77.50% ± 10.91% of LTD; n = 8; p = 0.04, Figure 4F ). These findings indicate that native group III mGluRs function to depress glutamate release onto MNCs, but that the function of these receptors is compromised by hemorrhage-induced release of NA.
HFS Induces Potentiation following LTD
Since the inactivation/internalization of presynaptic group III mGluRs in the hippocampus unmasks a metaplastic state (Pelkey et al., 2005 , we hypothesized that LTD NA , when accompanied by an a1-adrenoceptor-mediated loss of mGluR signaling, would provide the ideal conditions for activity-induced plasticity. Consistent with this hypothesis, we observed a rapid and persistent potentiation of eEPSCs in slices from hemorrhaged rats following HFS (3 3 100 Hz for 1 s, 10 s interval; 132.01% ± 8.29% of control 10-15 min post-HFS; n = 15; p = 0.0002; Figures 5A and 5B). During HFS the postsynaptic membrane potential was held constant at a hyperpolarized potential (V hold = À80 mV). This potentiation was accompanied by decreases in PPR (control 1.80 ± 0.19; post-HFS 1.49 ± 0.12; n = 15; p = 0.02), failure rate (control 0.14 ± 0.03; post-HFS 0.03 ± 0.01; p = 0.005), and CV (control 0.54 ± 0.03; post-HFS 0.45 ± 0.03; p = 0.0008; Figure 5C ). The same HFS applied to slices from control, nonhemorrhaged rats did not elicit synaptic potentiation (amplitude 98.73% ± 3.14% of control post-HFS, n = 11, p = 0.35; PPR 100.10% ± 3.47% of control post-HFS, p = 0.77; ketamine-anesthetized controls and naive rats pooled; Figures 5D and 5F ). Taken together, these observations strongly suggest that an in vivo challenge to body fluid homeostasis reduces Pr at glutamatergic synapses and leads to a state where the synapses have the potential for undergoing subsequent activity-dependent, presynaptic plasticity. Interestingly, prazosin microinjection into the PVN prior to hemorrhage prevented the synapses from undergoing activity-dependent potentiation following HFS (104.32% ± 11.47% of control post- HFS; n = 5; p = 0.89; Figures 5E and 5F). Thus, acute hypovolemic hemorrhage not only causes an a2-adrenoceptor-mediated decrease in glutamatergic synaptic efficacy, but also reveals an a1-adrenoceptor-mediated unmasking of activity-dependent presynaptic potentiation in response to HFS.
To determine if induction of LTD NA also unmasks a state permissible for subsequent synaptic potentiation similar to that observed following hemorrhage, we applied HFS to synapses that had undergone LTD NA while holding the postsynaptic membrane potential constant (V hold = À80 mV). HFS resulted in rapid repotentiation/de-depression of glutamatergic transmission that persisted for the duration of the recording (>20 min; HFS post-LTD NA 96.91% ± 8.10% of pre-NA control values; n = 11; p = 0.50; Figures 6A and 6B ). At these synapses, the potentiation was sufficient to completely reverse the changes in PPR (control 1.23 ± 0.13; LTD NA 1.85 ± 0.10; p = 0.008; post-HFS 1.25 ± 0.13; n = 5; p = 0.99), failure rate (control 0.08 ± 0.05; LTD NA 0.46 ± 0.11; p = 0.003; post-HFS 0.09 ± 0.04; p = 0.90), and CV (control 0.43 ± 0.06; LTD NA 0.72 ± 0.03; p = 0.01; post-HFS 0.46 ± 0.04; p = 0.99) observed during LTD NA ( Figure 6C ). These results indicate that LTP also has a presynaptic locus of expression and functionally represents the reverse process of LTD NA . The potentiation observed following LTD NA contrasts sharply with the absence of HFS-induced potentiation in naive (NA untreated) slices ( Figure 5D ), indicating that this plasticity depends upon previous activity of the network.
Since HFS potentiation, or metaplasticity, is observed when synapses are depressed and mGluRs are inactive, we conducted additional experiments to determine the necessity of individual component parts. First we considered the possibility that HFS-induced potentiation following LTD NA occurs because low Pr at synapses increases the ''ceiling'' of the synapses and makes them more amenable to potentiation in comparison to synapses with higher Pr (as in control) (Bi and Poo, 1998 Figure S2A ). Thus, we conclude that a reduction of Pr alone is not sufficient for metaplasticity at these synapses. Next, to confirm that a1-and a2-adrenoceptors specifically are necessary for metaplasticity, we applied another G protein-coupled receptor agonist baclofen (30 mM), which activates GABA B receptors and lowers Pr at glutamate synapses (Kombian et al., 1996) . Baclofen depressed eEPSCs, but subsequent HFS had no effect on synaptic strength ( Figure S2B ). We conducted additional experiments to determine the relative contributions of LTD and the mGluRs to the metaplasticity. We observed no potentiation in response to HFS at synapses that had undergone prior LTD with clonidine (62.18% ± 3.50% of control; n = 6; Figure S3A ). Finally, we asked whether inhibition of group III mGluRs was sufficient for activity-induced potentiation of synapses. In the presence of MSOP, HFS induced a pronounced posttetanic potentiation followed by a weak, longer lasting potentiation of eEPSCs that was not as robust as the potentiation observed after either LTD NA or hemorrhage (amplitude 118.23% ± 6.86% of control; n = 10; p = 0.02; PPR 85.056% ± 6.203% of control; p = 0.05; Figure S4 ). On the other hand, when BAPTA was included in the patch pipette to block induction of LTD NA and synapses were subsequently stimulated with HFS, no synaptic potentiation was observed ( Figure S3B ). Collectively, these results confirm that both LTD and mGluR inactivation are necessary for metaplasticity. Finally, if the HFS-dependent synaptic potentiation is a resetting of the synapses back to the naive state, then LTP should also be accompanied by a recovery of function at high-affinity group III mGluRs. To test this idea, we challenged synapses that were potentiated by HFS (following LTD NA ) with L-AP4. This caused a reduction in eEPSC amplitude and an increase in PPR equivalent to that observed in L-AP4-treated naive slices (73.05% ± 8.38% of post-HFS amplitude; n = 6; p = 0.04; Figure 7 ). These results indicate that HFS returns the synapses to a state that is functionally similar to the naive state (PPR return to control values, mGluRs are active).
DISCUSSION
The data presented here demonstrate that glutamate synapses in circuits regulating body fluid homeostasis are metaplastic. This metaplasticity requires the functional inactivation of presynaptic group III mGluRs and is evident both after the exposure of naive slices to NA and in slices prepared from animals subjected to an acute and precipitous loss of blood volume. In vitro application of NA or in vivo hemorrhage results in a persistent reduction in evoked glutamate release onto MNCs in the PVN. The reduction in Pr after NA (LTD NA ) requires the activation of postsynaptic a2-adrenoceptors, and the liberation of a retrograde signal that targets presynaptic CB1 receptors. Finally, the inactivation of mGluRs via a1-adrenoceptor stimulation primes the synapses, allowing a rapid, persistent potentiation of synaptic transmission in response to HFS of glutamatergic afferents. This LTP is accompanied by a recovery of mGluR function. Our results further support the hypothesis that mGluRs are critical molecular switches for the induction of metaplasticity and provide a link between the in vivo recruitment of neural circuits and the ability of the synapses within this circuit to undergo this powerful form of activity-dependent regulation. An intriguing finding in this study is that presynaptic CB1 receptors are critical for the induction of LTD NA . Previous studies in the hypothalamus have shown that eCBs can modulate synaptic transmission transiently following either presynaptic HFS or postsynaptic depolarization (Di et al., 2005a; Hirasawa et al., 2004) , via oxytocin receptor (Hirasawa et al., 2004; Oliet et al., 2007) or glucocorticoid receptor (Di et al., 2005b (Di et al., , 2009 Malcher-Lopes et al., 2006) stimulation. Our finding, however, demonstrates that eCBs contribute to an enduring plasticity in the hypothalamus and adds to the growing number of brain structures wherein eCBs mediate long-term synaptic plasticity (Chevaleyre et al., 2006; Lovinger, 2008) . The activation of a2-adrenoceptors is necessary for the induction of LTD NA and is consistent with observations that activation of G protein-coupled receptors recruits eCBs (Chevaleyre and Castillo, 2003; Kreitzer and Malenka, 2005; Robbe et al., 2002; Ronesi and Lovinger, 2005; Sung et al., 2001 ). Interestingly, a2-adrenoceptors have largely been assumed to be located on presynaptic nerve terminals, but aside from a few elegant demonstrations clearly showing a role for presynaptic a2-adrenoceptors in synaptic depression at glutamate synapses (Carey and Regehr, 2009; Delaney et al., 2007) , few studies have explicitly ruled out the possible involvement of a retrograde messenger. There are numerous observations in support of functional postsynaptic a2-adrenoceptors (Carr et al., 2007; Cathala et al., 2002; Li and van den Pol, 2005; Liu and Alreja, 1998; Shirasaka et al., 2007; Yamanaka et al., 2006) . Since activation of these G i/ocoupled receptors does not increase intracellular Ca 2+ , it is thought unlikely that they would participate in the production of retrograde signals. Recently, however, the D 2 -receptor, another G i/o -coupled receptor, has been shown to enhance eCB release in the striatum and ventral tegmental area (Giuffrida et al., 1999; Melis et al., 2004) and to be critical for eliciting eCB-LTD in the striatum Malenka, 2005, 2007) . In addition, these receptors can couple to PLD, a key enzyme in the biosynthetic pathway for eCBs (Basavarajappa, 2007) . Although it's not clear if PLD activation is important for production of eCBs in MNCs, the idea that PLD is at least partly reliant on and can be enhanced by intracellular Ca 2+ (Kano et al., 2009 ) is supported by our data demonstrating that long-term a2-mediated inhibition is blocked by inclusion of BAPTA in our patch pipette. Although the final molecular steps mediating LTD NA remain to be determined, there is compelling evidence in other systems that it may involve the persistent inhibition of presynaptic P/Q-type or N-type Ca 2+ channels (Brown et al., 2004; Hoffman and Lupica, 2000; Kreitzer and Regehr, 2001 ) and/or interference with release machinery (Chevaleyre et al., 2007; Gerdeman and Lovinger, 2001; Robbe et al., 2001) . Our experiments, however, argue against the latter assertion because LTD NA of eEPSCs was accompanied by a robust increase in the frequency of spontaneous EPSCs (sEPSCs) Bains, 2003, 2005) . Consistent with our previous investigation showing that activation of a1-adrenergic receptors inactivated presynaptic group III mGluRs (Gordon and Bains, 2003) , L-AP4 treatment failed to depress eEPSCs further after induction of LTD NA . This loss of mGluR function is mediated by increased PKC activity (Gordon and Bains, 2003; Macek et al., 1999) , but it is not clear whether mGluRs are internalized. Interestingly, internalization of mGluR7 is critical for the expression of metaplasticity at mossy fiberstratum lucidum interneuron (MF-SLIN) synapses in the hippocampus (Pelkey et al., 2005) . The internalization of mGluR7 is triggered by exposure to agonist (Pelkey et al., 2005 (Pelkey et al., , 2007 , whereas stable surface expression is dependent on PKC phosphorylation and receptor binding to the scaffolding protein PICK1 (Suh et al., 2008) . There are, however, two important distinctions between metaplasticity at MF-SLIN synapses and that described here. First, it appears that a different subtype of group III mGluRs is involved. At glutamate synapses onto MNCs, the high-affinity group III mGluRs (mGluR4 and 8) regulate neurotransmitter release, with little contribution from the low-affinity mGluR7 subtype (Panatier et al., 2004) (although see Schrader and Tasker, 1997) . Our investigations using a concentration of L-AP4 (25 mM) that targets only high-affinity group III mGluRs are consistent with these observations. Second, at MF-SLIN synapses, mGluR inactivation is dependent on prolonged binding of agonist (glutamate) to the receptors. By contrast, inactivation of mGluRs in our study depends on the activation of a second, independent chemical signal, NA. Whether mGluRs actually undergo internalization following NA is unresolved. Recent work demonstrating internalization and desensitization of mGluR4 following activation of PKC by phorbol ester treatment or Ga q -linked G protein-coupled receptor activation (Mathiesen and Ramirez, 2006) offers support for the internalization hypothesis in our scenario. Since the internalization of mGluR7 is critical to the expression of metaplasticity at MF-SLIN synapses (Pelkey et al., 2005) , it seems plausible that high-affinity group III mGluR internalization is also necessary for metaplasticity at MNC glutamate synapses.
Based on our paired-pulse, CV, and failure analyses, both LTD NA and HFS potentiation have a presynaptic locus of expression, indicating that potentiation functionally represents the reverse process of LTD. Importantly, HFS not only restored presynaptic release probability, but caused a gain of mGluR function, suggesting that synapses return to a state that is functionally identical to pre-LTD NA induction. This presynaptic potentiation following HFS occurs in the absence of postsynaptic depolarization and is fundamentally different from NMDAreceptor-dependent plasticity described previously at glutamate synapses onto MNCs (Panatier et al., 2006a (Panatier et al., , 2006b .
Our work adds to a growing metaplasticity field that highlights the requirement for regulatory mechanisms to maintain synaptic efficacy within a functional dynamic range (Abraham, 2008; Clem et al., 2008) . Furthermore, it provides a critical proof that recent demonstrations of presynaptic mGluRs as gatekeepers for a novel form of metaplasticity (Pelkey et al., 2005 (Pelkey et al., , 2006 can be extended to suggest that presynaptic mGluRs are also a mechanism to alter synaptic strength in response to a physiologically relevant in vivo challenge. How might mGluR-mediated metaplasticity in the hypothalamus contribute to restoration of body fluid homeostasis? One possibility is that the metaplasticity we describe here represents transitions of glutamate synapses through multiple functional states that tightly regulate the activity of MNCs and therefore the appropriate release of hormones from the posterior pituitary. In other words, internal homeostasis is maintained by responding immediately and effectively to a challenge, operating at a new (transient) setpoint, and then resetting the system. This includes an increase in Pr Bains, 2003, 2005) and an NA recruitment of astrocytes that promotes AMPA receptor insertion ) that initially drives MNCs, followed by an eCB-mediated persistent reduction in Pr as the system begins to adapt to the challenge, and finally, an activity-dependent resetting that is only possible if presynaptic mGluRs are first inactivated.
EXPERIMENTAL PROCEDURES Brain Slice Preparation
All experiments were performed according to protocols approved by the University of Calgary Animal Care and Use Committee in accordance with Canadian Council on Animal Care guidelines. Male Sprague-Dawley rats (postnatal day 21 [P21]-P40) were anaesthetized using isoflurane and then decapitated. The brain was quickly removed and placed in ice-cold slicing solution containing (in mM) NaCl 87, KCl 2.5, NaHCO 3 25, MgCl 2 7, NaH 2 PO 4 1.25, glucose 25, and sucrose 75 saturated with 95%/5% O 2 /CO 2 . The brain was blocked, mounted on a vibrating slicer (Leica, Nussloch, Germany), and submerged in ice-cold slicing solution. Coronal slices (250 mm) of the hypothalamus containing the PVN were cut and transferred to an incubating chamber containing ACSF at 32 C for 45 min. The ACSF contained (in mM) NaCl 126, KCl 2.5, NaHCO 3 25, MgCl 2 1.2, NaH 2 PO 4 1.2, glucose 11, CaCl 2 2.4, and ascorbic acid 1 saturated with 95%/5% O 2 /CO 2 . Slices were maintained for a minimum of 45 min at room temperature (21 C-24 C) before recording.
Electrophysiology
Hypothalamic slices were transferred to a recording chamber and superfused with 32 C-34 C ACSF at a flow rate of 1-2 ml/min. Whole-cell recordings were obtained from MNCs visualized with an AxioskopII FS Plus (Zeiss, Oberkochen, Germany) upright microscope fitted with infrared differential interference contrast optics. MNCs were identified based on their morphology and welldefined electrophysiological characteristics (Luther and Tasker, 2000) . Recordings were obtained using borosilicate glass microelectrodes (tip resistance 3-5 MU) filled with a solution containing (in mM) K-gluconate 123, NaCl 8, EGTA 1, HEPES 16, MgCl 2 2, K 2 ATP 0.3, and Na 3 GTP 0.3. For experiments where BAPTA was included in the pipette solution, a minimum of 15 min was allowed for intracellular diffusion. Recordings were accepted for analysis if changes in access resistance were <15%. Cells were voltage clamped at À80 mV and the perfusate always contained picrotoxin (100 mM; Sigma-Aldrich, St. Louis, MO) to block GABA A -mediated synaptic currents. Glutamatergic fibers were stimulated with an extracellular patch pipette filled with ACSF that was always positioned lateral to the PVN in approximately the same location. EPSCs were evoked at a rate of 0.1 Hz and paired-pulse responses were obtained by applying a pair of synaptic stimuli 50 ms apart. Only synapses that displayed a high degree of synchronous release 0-5 ms after the stimulation were analyzed. For high HFS, afferents were stimulated at 100 Hz for 1 s, repeated three times 10 s apart. Signals were amplified using the Multiclamp 700B amplifier (Molecular Devices, Union City, CA), low-pass filtered at 1 kHz, and digitized at 10 kHz using the Digidata 1322 (Molecular Devices). Data were collected (pClamp 9.0, Molecular Devices) and stored on a computer for offline analysis. Evoked currents were analyzed using Clampfit 9 (Molecular Devices). The amplitude of the synaptic current was calculated from the baseline (current before evoked response) to the peak of each evoked. For clarity, the stimulus artifacts have been removed digitally from the traces depicted. PPRs (50 ms interstimulus interval), CV, and failure rates were measured over 5 min epochs of 30 eEPSCs each. To exclude possible contributions from AMPA receptor insertion in response to NA application , recordings for the HFS experiments in Figure 6 were performed with an intracellular solution containing EGTA (10 mM). This concentration of EGTA is sufficient to block postsynaptic AMPA receptor insertion, but is not adequate to block the induction of LTD NA . Results are expressed as means ± SEM. Significance was determined using a Student's t test or a one-way ANOVA with Tukey's post hoc comparison where appropriate with significance level of p < 0.05.
Hemorrhage
Rats were anaesthetized with ketamine-xylazine (100 mg/kg). Approximately 25% of blood volume (Lee and Blaufox, 1985) was removed by cardiac puncture with a heparinized syringe over approximately 1 min. Brain slices were prepared after either 2 or 30 min after hemorrhage, or an equal time anesthetized without hemorrhage.
Microinjection of Chemicals into the PVN Under ketamine-xylazine (100 mg/kg) anesthesia, rats were microinjected with prazosin (10 nmol), yohimbine (10 nmol), or vehicle (25% ACSF, 75% DMSO; Blevins et al., 2002) . Injections into the magnocellular subnucleus of the PVN were performed using a stereotaxically fixed 10 ml Hamilton microsyringe. The stereotaxic coordinates for the PVN were as follows: 1.1-1.3 mm posterior to Bregma, 1.6-1.7 mm from the midline at a 10 angle (to avoid bleeding from the superior sagittal sinus), and 7.7-8.0 mm below the surface of the cortex (Paxinos and Watson, 2005) . A volume of 1 ml was delivered over 1-2 min into the PVN to allow diffusion of the chemical. Each animal was injected unilaterally and either the right or left hemisphere was chosen randomly. Rats were hemorrhaged approximately 2-4 min after the injections. Injection sites were visually identified in hypothalamic slices by imaging FluoSpheres (0.1 mm, red fluorescent; Invitrogen, Carlsbad, CA) that were included with the vehicle at a dilution of 1:100. Injection sites were imaged using a Zeiss AxioskopII FS Plus (4X objective lens) and epifluorescence images were captured using a Retiga Exi camera (Q Imaging, Surrey, BC, Canada) with QCapture software.
SUPPLEMENTAL DATA
Supplemental data for this article include four Supplemental Figures and can be found at http://www.cell.com/neuron/supplemental/S0896-6273(09)00430-9.
